\documentclass[aspectratio=169]{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
\usetheme{Warsaw}
%\usetheme{Antibes}
\usecolortheme{beaver}
%\usecolortheme{seahorse}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
%\title{Network based drug repurposing for Alzheimer's disease}
%\title{A multi-OMIC network based approach to drug repurposing for Alzheimer's}
\subtitle{A subtitle may be shorter and more technical}
\author{poster \#1}
\date{Attila Jones}

\begin{document}

\begin{frame}{Drug Repurposing Opportunities for Alzheimerâ€™s Disease from
	Multiomics}
	{\emph{Attila Jones$^1$, Evan Wu$^2$, Sudhir Varma, Hae Kyung Im$^2$, Madhav Thambisetty$^1$}\\
		$1$: Clinical \& Translational Neuroscience Section, LBN, $2$: University
	of~Chicago}

\begin{columns}[t]
\begin{column}{0.35\textwidth}
\begin{center}
	Network proximity $\sim$
	efficiacy
\end{center}

\includegraphics[width=1.0\columnwidth]{../../../figures/from-others/cheng-desai-2018-Nat-comm-Fig4a-nolabel.png}

\tiny
Cheng et al 2018 Nat Commun
\end{column}

\begin{column}{0.7\textwidth}
\begin{center}
	Workflow
\end{center}

\includegraphics[width=\columnwidth]{../../../figures/by-me/repurposing-study-desing/repurposing-study-design.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Results}
	

\begin{columns}[t]
\begin{column}{0.5\textwidth}
\begin{center}
	Selected top drugs
\end{center}
\footnotesize
\begin{tabular}{rll}
	rank & indication class    & targets \\
	\hline
	4    & Neuroprotective     & RGS4, GPR84 \\
	28   & Anticholelithogenic & RGS4, NTCP2 \\
	51   & Anti-Urolithic      & CP3A4, RGS4 \\
	%322  & Anti-Urolithic      & GEMI, LMNA, PLK1, ... \\
\end{tabular}
\end{column}

\begin{column}{0.5\textwidth}
\begin{center}
	Experimental validation\\
\end{center}

\includegraphics[width=0.8\columnwidth]{../../../figures/from-others/CTNS-cell-culture-screen.png}
\end{column}
\end{columns}
\end{frame}

\end{document}


\begin{columns}[t]
\begin{column}{0.5\textwidth}

\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
